Is Zimmer Biomet (ZBH) overvalued or fairly valued?

MarketChacha shows Zimmer Biomet's valuation in context — a forward P/E of about 9.8, a price-to-book of about 1.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Zimmer Biomet (ZBH)?

Zimmer Biomet last traded at $88.20 (-0.8% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Zimmer Biomet

ZBH · NYSE · Healthcare · United States

$88.20-0.8%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:38 PM

Snapshot

TickerZBH

ExchangeNYSE

SectorHealthcare

IndustryMedical Devices

CountryUnited States

Employees17,000

HeadquartersWarsaw, United States

Market cap$17.1B

P/B1.3

Volume367.77K

Websitewww.zimmerbiomet.com

Filings tracked0

About Zimmer Biomet

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.2%
Institutions99.8%
Public & other0.0%

1,253 institutional holders

As reported by Yahoo Finance.

Top holders

Dodge & Cox Inc.12.17%
Blackrock Inc.7.93%
Harris Associates L.P.6.70%
Vanguard Capital Management LLC6.61%
Capital International Investors4.71%
State Street Corporation4.56%
Vanguard Portfolio Management LLC4.47%
Price (T.Rowe) Associates Inc4.14%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $2.0B · EPS 1.88

Est. earnings growth -1.2%

Next fiscal year

Rev $8.8B · EPS 9.00

Est. earnings growth +6.2%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$79.1252-wk range$108.29

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about ZBH

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.